Advertisement
Advertisement
U.S. markets close in 4 hours 50 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Amphastar Pharmaceuticals, Inc. (AMPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.17+0.07 (+0.35%)
As of 11:07AM EST. Market open.
Advertisement

Amphastar Pharmaceuticals, Inc.

11570 6th Street
Rancho Cucamonga, CA 91730
United States
909 980 9484
http://www.amphastar.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees1,980

Key Executives

NameTitlePayExercisedYear Born
Dr. Ziping LuoChairman, Chief Scientist & COO1.23MN/A1950
Dr. Yongfeng ZhangCo-founder, Pres, CEO, Chief Scientific Officer & Director1.98MN/A1947
Mr. William J. Peters M.B.A.CFO, Treasurer & Exec. VP of Fin.1.09M106.67k1968
Mr. Jacob Liawatidewi M.B.A.Exec. VP of Corp. Admin. Center, Sales & Marketing and Corp. Sec.749.57k252.84k1974
Mr. Rong ZhouExec. VP of Production Center768.66k151.28k1959
Dan DischnerVP of Corp. CommunicationsN/AN/AN/A
Tony MarrsSr. VP of Regulatory Affairs and Clinical OperationsN/AN/AN/A
Mr. Peter LangoshVP of Operational Improvement and VP of Internal AuditN/AN/A1953
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Corporate Governance

Amphastar Pharmaceuticals, Inc.’s ISS Governance QualityScore as of September 26, 2021 is 8. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 6; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement